新股孖展统计 | 9月29日

Core Viewpoint - The new IPO of Changfeng Pharmaceutical (02652) has raised a total of HKD 820.086 million, with an oversubscription rate exceeding 1343 times [1] Group 1: IPO Details - The total amount raised by Changfeng Pharmaceutical is HKD 820.086 million [1] - The company has received subscriptions from various brokers, including Futu, which contributed HKD 457 million, and Huasheng, which contributed HKD 26.8 million [1] - The overall subscription amount from other brokers totals HKD 158.535 million [1] Group 2: Subscription Performance - The IPO was significantly oversubscribed, with an oversubscription rate of over 1343 times [1] - The interest in the IPO indicates strong market demand for Changfeng Pharmaceutical's shares [1]